Next Article in Journal
A Threat- and Efficacy-Based Framework to Understand Confidence in Vaccines among the Public Health Workforce
Next Article in Special Issue
Nonclinical Development of BCG Replacement Vaccine Candidates
Previous Article in Journal / Special Issue
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence
Vaccines 2013, 1(1), 58-76; doi:10.3390/vaccines1010058

Notes on Article Versions

NoteDate
Article Published25 January 2013 09:42 CET
article pdf uploaded.25 January 2013 09:43 CET
article word file uploaded.25 January 2013 09:43 CET
article files uploaded.25 January 2013 09:43 CET
article pdf uploaded.30 January 2013 09:47 CET
article html file updated7 February 2013 18:00 CET
article html file updated8 February 2013 09:40 CET
Article Edited21 February 2013 14:57 CET
Article Edited31 January 2014 10:41 CET
article xml file uploaded16 December 2014 04:58 CET
article html file updated16 December 2014 04:58 CET
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert